Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 5:35 PM UTC
| NCT Number | NCT06747585 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 170 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Alentis Therapeutics AG |
| Last Updated on CT.gov | June 29, 2026 (3 weeks ago) |
As of July 20, 2026: Clinical trial NCT06747585 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 8 locations across the United States. The study is sponsored by Alentis Therapeutics AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06747585 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06747585 was last updated 3 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.